arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ENvue Medical, Inc.

FEED

$0.40 ▲ +0.02 (+3.95%) at close

13 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

ENvue Medical, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth -0.2% ↘

Op. Margin None

ROIC -67.2% ↗

FCF / Share $-15.01

Trailing P/E —

Price / Book 0.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

13-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.55M

— -0.2% —

Net Income Profit after all expenses

$-18.18M

↓ -390.8% —

Operating Margin Operating profit as % of sales

-140.0%

↑ +7.0% —

FCF / Share Free cash flow per share

$-15.01

↑ +33.7% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↑

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue Growth YoY (%)	-0.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-102%)	12.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+51%)	203.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2445%)	-55.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-795%)	172.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2051%)	17.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+119%)	66.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+733%)	33.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+313%)	4.4% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-45%)	55.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+597%)	-27.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-445%)	—	—
EPS Growth YoY (%)	80.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-488.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-507.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	66.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-390.8% Weak ↓ Weak Declining Year-over-year change in net income	0.2% Caution ↑ Caution Improving Year-over-year change in net income	31.9% Excellent ↑ Excellent Improving Year-over-year change in net income	61.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-230.1% Weak ↓ Weak Declining Year-over-year change in net income	25.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-39.5% Weak ↓ Weak Declining Year-over-year change in net income	16.3% Good ↑ Good Improving Year-over-year change in net income	-75.4% Weak ↓ Weak Declining Year-over-year change in net income	1.8% Caution Caution Year-over-year change in net income	-9.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	—	-356.8% Weak Weak Year-over-year change in free cash flow	-42.7% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	50.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	14.7% Good ↓ Good Declining Compound annual revenue growth over 3 years	54.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	12.4% Good ↓ Good Declining Compound annual revenue growth over 3 years	74.7% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	37.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	32.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	29.3% Excellent Excellent Compound annual revenue growth over 3 years	5.6% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	32.6% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	37.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	48.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	25.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	49.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	33.5% Excellent Excellent Compound annual revenue growth over 5 years	21.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Operating Margin (%) (%)	—	-140.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1034%)	-150.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1103%)	—	-335.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2335%)	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	1.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	-144.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1307%)	-162.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1455%)	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-369.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-98.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-157.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-257.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.29x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Return on Invested Capital (%)	-67.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-574.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-86.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-156.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-90.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-197.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-381.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-901.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-85.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	96.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	688.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	22.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-55.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-98.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-85.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-65.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-57.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-253.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-272.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-63.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-468.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-167.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-54.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-462%)	—	-93.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-720%)	-168.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1223%)	-226.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1608%)	-180.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1305%)	—	—	-136.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1011%)	113.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+655%)	—	47.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+214%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Interest Coverage (x)	-915.56x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-25.45x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-32.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-343.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-83.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-21.91x Weak Weak Operating income divided by interest expense Optimal: > 5x	-3.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-4.22M	$-752.00K	—	—	—	$-7.14M	$-1.34M	$-896.00K	$-4.36M	$-106.00K	$-1.61M	$-90.00K	$-94.00K

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Revenue per Share (USD)	$4.06	—	$14.35	$0.53	$1.35	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-26.69	$-137.30	$-23.32	$-3.84	$-11.35	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-15.01	—	$-22.65	$-4.96	$-3.47	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$53.29	—	$21.44	$1.97	$4.51	$0.12	$0.32	$0.12	$0.92	$-0.95	$-0.08	$-34.33	—
Tangible Book Value per Share (USD)	$0.06	—	$21.44	$1.97	$4.51	$0.12	$0.32	$0.12	$0.92	$-0.95	$-0.08	$-34.33	—
Basic Weighted Avg Shares (shares)	628,534	26,985	159,105	1.42M	1.26M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Working Capital (USD)	$611.00K	$609.00K	$4.03M	$3.29M	$6.44M	$5.07M	$1.43M	$590.00K	$3.72M	$-344.00K	$1.48M	$-5.25M	—
Total Equity (USD)	$33.50M	$627.00K	$3.99M	$3.23M	$6.31M	$2.39M	$1.35M	$463.00K	$3.63M	$-2.50M	$-209.00K	$-5.62M	$-3.30M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗
Sales/Revenue/Turnover (USD)	$2.55M	$2.56M	$2.28M	$752.00K	$1.70M	$623.00K	$530.00K	$318.00K	$239.00K	$229.00K	$147.00K	$203.00K	—
Depreciation Expense (USD)	$897.00K	$1.00K	$1.00K	$1.00K	$2.00K	$2.00K	$4.00K	$6.00K	$5.00K	$7.00K	$9.00K	$9.00K	—
Net Income, GAAP (USD)	$-18.18M	$-3.71M	$-3.71M	$-5.45M	$-14.28M	$-4.33M	$-5.79M	$-4.15M	$-4.96M	$-2.83M	$-2.88M	$-2.65M	—
Operating Cash Flow (USD)	$-9.37M	$-2.52M	$-3.60M	$-7.04M	$-4.37M	$-3.39M	$-3.87M	$-3.55M	$-2.18M	$-1.53M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 50 quarters

ENvue Medical, Inc.

Analytical Summary

13-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare FEED with peers